Self-Sampling Blood Collection And Storage Device Global Market Report 2025

The self-sampling blood collection and storage device market size has grown rapidly in recent years. It will grow from $0.83 billion in 2024 to $0.95 billion in 2025 at a compound annual growth rate (CAGR) of 13.9%. The growth during the historical period has been driven by the increasing prevalence of chronic diseases, a shift toward preventive healthcare, advancements in micro-sampling, and the expansion of telehealth services. Rising awareness about self-testing and the growing trend of healthcare consumerization have also contributed to this growth.

The self-sampling blood collection and storage device market size is expected to see rapid growth in the next few years. It will grow to $1.58 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. This anticipated growth is supported by the increasing acceptance of at-home healthcare solutions, the growing expansion of telehealth and remote patient monitoring, and the rising incidence of chronic and lifestyle-related diseases. Additionally, the demand for personalized and preventive healthcare continues to rise, alongside ongoing advancements in healthcare digitization. Notable trends expected to shape the market include the development of microneedle and painless sampling technologies, innovations in dried blood spot (DBS) technology, integration of lab-on-a-chip and microfluidic systems, and the emergence of smart blood collection devices featuring IoT connectivity and AI-powered diagnostic and data analysis capabilities.

The rising consumer demand for at-home healthcare solutions is anticipated to drive the growth of the self-sampling blood collection and storage devices market in the future. At-home healthcare solutions involve medical services, devices, and technologies that allow individuals to manage and monitor their health remotely, eliminating the need to visit clinics or hospitals. This demand is growing because of the convenience it offers by reducing travel and wait times. Self-sampling blood collection and storage devices support these solutions by allowing easy and accurate sample collection at home, enhancing patient comfort, simplifying the process, and enabling timely diagnostics to improve healthcare accessibility. For example, the U.S. Bureau of Labor Statistics projects a 21% growth in employment for home health and personal care aides from 2023 to 2033, which is significantly faster than the average for all occupations. Hence, the increasing preference for at-home healthcare is boosting the market for these devices.

Leading companies in the self-sampling blood collection and storage device market are focusing on creating innovative products to improve sample quality, ease of use, and diagnostic precision. These new self-sampling devices enable individuals to collect blood samples with minimal or no help from healthcare professionals. For instance, in February 2023, Capitainer AB, a medical technology firm based in Sweden, introduced Capitainer B 50, a self-sampling blood collection card that allows patients to collect and store larger blood volumes. This device permits the collection of two precise 50 µL blood samples from a finger stick, supporting a broader range of laboratory tests. It features an accurate filling mechanism that automatically meters the blood, reducing risks of over- or under-filling, and includes an indicator to confirm proper sampling.

In January 2022, Trajan Group Holdings Limited, an Australian medical device company, acquired Neoteryx LLC for an undisclosed sum. This acquisition aims to enhance Trajan’s microsampling capabilities, promote the global adoption of remote blood collection, and advance innovation in decentralized, data-driven healthcare solutions. Neoteryx LLC is a US-based company specializing in self-sampling blood collection and storage devices.

Major players in the self-sampling blood collection and storage device market are F. Hoffmann-La Roche AG, Danaher Corporation, Becton, Dickinson and Company (BD), DBS System SA, Quest Diagnostics, Terumo Corporation, Sysmex Corporation, Qiagen N.V., PerkinElmer Inc., Sarstedt AG & Co. KG, Greiner Bio-One International GmbH, Trajan Group Holdings Limited, Tasso Inc., PanoHealth, Boston Microfluidics Inc., LAMEDITECH Co Ltd., YourBio Health Inc., Capitainer, Drawbridge Health Inc., and Spot On Sciences.

North America was the largest region in the self-sampling blood collection and storage device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in self-sampling blood collection and storage device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the self-sampling blood collection and storage device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A self-sampling blood collection and storage device is a medical instrument that enables individuals to safely and conveniently collect their own blood samples, typically through a fingerstick or micro-needle method. Its main function is to facilitate remote diagnostic testing by collecting, stabilizing, and preserving small quantities of blood for laboratory examination. These devices promote at-home health monitoring and minimize the necessity for visits to healthcare facilities.

The primary types of self-sampling blood collection and storage devices include kits, tubes, lancets, and others. Self-sampling blood collection kits are all-in-one packages designed for individuals to gather their own blood samples at home. These kits usually contain lancets for fingertip pricking, collection tubes or devices, alcohol swabs, bandages, and comprehensive instructions. They are particularly beneficial for at-home health monitoring and clinical trials, providing ease of use and lowering the need for professional support. These devices are made from various materials such as plastic, glass, silicone, metal, and composites and collect samples including blood, urine, and saliva. Their applications span genetic testing, infectious disease testing, drug testing, and blood chemistry analysis across end users like hospitals, diagnostic laboratories, research institutes, home care settings, and others.

The self-sampling blood collection and storage device market research report is one of a series of new reports that provides self-sampling blood collection and storage device market statistics, including self-sampling blood collection and storage device industry global market size, regional shares, competitors with a self-sampling blood collection and storage device market share, self-sampling blood collection and storage device market segments, market trends and opportunities, and any further data you may need to thrive in the self-sampling blood collection and storage device industry. This self-sampling blood collection and storage device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The self-sampling blood collection and storage devices market consists of sales of capillary blood collection kits, blood collection tubes and microtubes, integrated collection and testing devices, storage and transport solutions, and accessories and support tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.